September 06, 2018 China comes of age Chi-Med is not alone in seeing Chinese approval as the prelude to a regulatory green light in the west.
October 12, 2017 Another huge quarter for biotech flotations Another billion dollar quarter for biotech IPOs signals that investor appetite for high-risk offerings is strong.
